Centene Corp bumped up its 2026 profit outlook Tuesday, following a first-quarter earnings beat that signaled tighter reins on medical expenses. Shares surged more than 6% in early trade, according to Reuters.
Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predictedinvesting.com. Likewise, revenue for the quarter reached $50.1 billion, surpassing the $49.3 billion consensus and growing 12% year-over-yearinvesting.com. This robust growth was fueled by higher premium yields and an expanding customer base – particularly gains in Medicare Advantage enrollments – along with contributions from recent acquisitions in Elevance’s Carelon health services unittradingview.com. These factors combined to help Elevance smash its Q3 forecasts, showcasing strong demand and pricing power in its health benefits business.
Wall Street’s major indexes extended their rally into the first days of October, defying the political gridlock in Washington. On Friday, October 3, the benchmark S&P 500 edged up less than 0.1% to 6,715.79, just enough to mark a record closing high reuters.com. The Dow Jones Industrial Average climbed 0.5% to 46,758.28, also a record finish reuters.com. Meanwhile, the Nasdaq Composite slipped about –0.3% to 22,780.5, snapping its winning streak as some tech shares weakened reuters.com. Notably, all three indexes had hit intraday all-time highs during Friday’s session before a bit of profit-taking into the close reuters.com.
July 9, 2026, 3:17 AM EDT. REG - iShares II PLC market data is sourced from ICE Data Services with reference data pulled from FactSet. The report covers CUSIP identifiers and SEC filings collected through Quartr. Data rights come via FactSet Research Systems, the American Bankers Association, and TradingView. Coverage reflects current regulatory and market disclosures tied to this instrument.